Skip to content

Clinical trials

Completed Phase 4 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 4 Status: Completed Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
200310
200413
200512
200610
200710
200819
200910
20108
20115
20126
201310
20148
20154
20166
20172
20183
20194
20211
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed153

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company21
Massachusetts General Hospital18
Shire7
Children's Hospital Medical Center, Cincinnati5
NYU Langone Health4
Icahn School of Medicine at Mount Sinai3
New York State Psychiatric Institute3
Ortho-McNeil Janssen Scientific Affairs, LLC3
Seattle Children's Hospital3
University of Arizona3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity153
Substance-Related Disorders7
Autistic Disorder4
Dyslexia4
Spasm4
Asperger Syndrome3
Conduct Disorder3
Oppositional Defiant Disorder3
Anxiety Disorders2
Attention Deficit and Disruptive Behavior Disorders2

Trials

Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.